Teresa A. Collins

Darwin Building, Cambridge Science Park, Milton Road, CB4, 0WG
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors.

AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 12, 2024

Shigella sonnei utilises colicins during inter-bacterial competition.

Shigella sonnei utilises colicins during inter-bacterial competition.

Journal: Microbiology (Reading, England)

Published: February 20, 2024

A novel cardiovascular systems model to quantify drugs effects on the inter-relationship between contractility and other hemodynamic variables.

A novel cardiovascular systems model to quantify drugs effects on the inter-relationship between contractility and other hemodynamic variables.

Journal: CPT: pharmacometrics & systems pharmacology

Published: October 21, 2021

Systems Modeling to Quantify Safety Risks in Early Drug Development: Using Bifurcation Analysis and Agent-Based Modeling as Examples.

Systems Modeling to Quantify Safety Risks in Early Drug Development: Using Bifurcation Analysis and Agent-Based Modeling as Examples.

Journal: The AAPS journal

Published: October 24, 2020

Importance of Stability Analysis When Using Nonlinear Semimechanistic Models to Describe Drug-Induced Hematotoxicity.

Importance of Stability Analysis When Using Nonlinear Semimechanistic Models to Describe Drug-Induced Hematotoxicity.

Journal: CPT: pharmacometrics & systems pharmacology

Published: January 23, 2020

Current and future approaches to nonclinical cardiovascular safety assessment.

Current and future approaches to nonclinical cardiovascular safety assessment.

Journal: Drug discovery today

Published: December 13, 2019

Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumors.

Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumors.

Journal: Science translational medicine

Published: August 24, 2019

Quantifying Drug-Induced Bone Marrow Toxicity Using a Novel Haematopoiesis Systems Pharmacology Model.

Quantifying Drug-Induced Bone Marrow Toxicity Using a Novel Haematopoiesis Systems Pharmacology Model.

Journal: CPT: pharmacometrics & systems pharmacology

Published: July 08, 2019

Semi-mechanistic modelling platform to assess cardiac contractility and haemodynamics in preclinical cardiovascular safety profiling of new molecular entities.

Semi-mechanistic modelling platform to assess cardiac contractility and haemodynamics in preclinical cardiovascular safety profiling of new molecular entities.

Journal: British journal of pharmacology

Published: January 28, 2019

Understanding Hematological Toxicities Using Mathematical Modeling.

Understanding Hematological Toxicities Using Mathematical Modeling.

Journal: Clinical pharmacology and therapeutics

Published: January 10, 2018

A tutorial on model informed approaches to cardiovascular safety with focus on cardiac repolarisation.

A tutorial on model informed approaches to cardiovascular safety with focus on cardiac repolarisation.

Journal: Journal of pharmacokinetics and pharmacodynamics

Published: November 15, 2017

Quantifying the relationship between inhibition of VEGF receptor 2, drug-induced blood pressure elevation and hypertension.

Quantifying the relationship between inhibition of VEGF receptor 2, drug-induced blood pressure elevation and hypertension.

Journal: British journal of pharmacology

Published: May 26, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026